Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 26-Apr-24 5:22 PM View:  | Geffner Michael Chief Medical Officer | Immunovant, Inc. (IMVT) | 24-Apr-24 | Private Sale | 3,261 | $28.90 | $94,242.90 | (2%) 144.88K to 141.62K | |
| 26-Apr-24 5:18 PM View: | Levine Mark S. Chief Legal Officer | Immunovant, Inc. (IMVT) | 24-Apr-24 | Private Sale | 3,963 | $28.90 | $114,531.00 | (1%) 347.12K to 343.16K | |
| 26-Apr-24 5:20 PM View: | Stout Jay S Chief Technology Officer | Immunovant, Inc. (IMVT) | 24-Apr-24 | Private Sale | 7,239 | $28.90 | $209,207.00 | (5%) 154.98K to 147.74K | |
| 19-Apr-24 6:01 PM View: | Barnett Eva Renee Chief Financial Officer | Immunovant, Inc. (IMVT) | 17-Apr-24 | Private Sale | 12,253 | $29.06 | $356,049.00 | (3%) 371.71K to 359.46K | |
| 19-Apr-24 6:05 PM View: | MacIas William L. Chief Medical Officer | Immunovant, Inc. (IMVT) | 17-Apr-24 | Private Sale | 8,280 | $29.06 | $240,602.00 | (2%) 385.93K to 377.65K | |
| 19-Apr-24 5:59 PM View: | Butchko Julia G. Chief Development Officer | Immunovant, Inc. (IMVT) | 17-Apr-24 | Private Sale | 10,115 | $29.06 | $293,923.00 | (2%) 461.74K to 451.63K | |
| 19-Apr-24 5:57 PM View: | Salzmann Peter Chief Executive Officer Director | Immunovant, Inc. (IMVT) | 17-Apr-24 | Private Sale | 34,079 | $29.06 | $990,269.00 | (3%) 1.09M to 1.05M | |
| 19-Apr-24 6:06 PM View: | Levine Mark S. Chief Legal Officer | Immunovant, Inc. (IMVT) | 17-Apr-24 | Private Sale | 9,827 | $29.06 | $285,554.00 | (3%) 356.95K to 347.12K | |
| 10-Apr-24 4:14 PM View: | Salzmann Peter Chief Executive Officer Director | Immunovant, Inc. (IMVT) | 09-Apr-24 | Private Sale | 4,807 | $31.18 | $149,882.00 | (< 1%) 1.09M to 1.09M | |
| 10-Apr-24 4:18 PM View: | Barnett Eva Renee Chief Financial Officer | Immunovant, Inc. (IMVT) | 09-Apr-24 | Private Sale | 3,689 | $31.18 | $115,023.00 | (< 1%) 375.4K to 371.71K | |
| 10-Apr-24 4:16 PM View: | Butchko Julia G. Chief Development Officer | Immunovant, Inc. (IMVT) | 09-Apr-24 | Private Sale | 1,053 | $31.18 | $32,832.50 | (< 1%) 462.8K to 461.74K | |
| 04-Apr-24 4:54 PM View: | Fromkin Drew J Director | Immunovant, Inc. (IMVT) | 02-Apr-24 | Grant | 11,255 | -- | -- | 13% 88.66K to 99.91K | |
| 04-Apr-24 4:37 PM View: | Levine Mark S. Chief Legal Officer | Immunovant, Inc. (IMVT) | 02-Apr-24 | Grant | 54,978 | -- | -- | 18% 301.97K to 356.95K | |
| 04-Apr-24 4:27 PM View: | Barnett Eva Renee Chief Financial Officer | Immunovant, Inc. (IMVT) | 02-Apr-24 | Grant | 54,978 | -- | -- | 17% 320.42K to 375.4K | |
| 04-Apr-24 4:50 PM View: | Hughes Douglas J. Director | Immunovant, Inc. (IMVT) | 02-Apr-24 | Grant | 11,255 | -- | -- | 10% 113.75K to 125.01K | |
| 04-Apr-24 4:46 PM View: | Pande Atul Director | Immunovant, Inc. (IMVT) | 02-Apr-24 | Grant | 11,255 | -- | -- | 11% 103.16K to 114.41K | |
| 04-Apr-24 4:39 PM View: | Stout Jay S Chief Technology Officer | Immunovant, Inc. (IMVT) | 02-Apr-24 | Grant | 54,978 | -- | -- | 55% 100.0K to 154.98K | |
| 04-Apr-24 4:48 PM View: | Migausky George V Director | Immunovant, Inc. (IMVT) | 02-Apr-24 | Grant | 11,255 | -- | -- | 10% 109.81K to 121.06K | |
| 04-Apr-24 4:29 PM View: | Butchko Julia G. Chief Development Officer | Immunovant, Inc. (IMVT) | 02-Apr-24 | Grant | 54,978 | -- | -- | 13% 407.82K to 462.8K | |
| 04-Apr-24 4:31 PM View: | Geffner Michael Chief Medical Officer | Immunovant, Inc. (IMVT) | 02-Apr-24 | Grant | 54,978 | -- | -- | 61% 89.9K to 144.88K | |
| 04-Apr-24 4:23 PM View: | Salzmann Peter Chief Executive Officer Director | Immunovant, Inc. (IMVT) | 02-Apr-24 | Grant | 160,534 | -- | -- | 17% 931.23K to 1.09M | |
| 04-Apr-24 4:34 PM View: | MacIas William L. Chief Medical Officer | Immunovant, Inc. (IMVT) | 02-Apr-24 | Grant | 54,978 | -- | -- | 17% 330.95K to 385.93K | |
| 04-Apr-24 4:44 PM View: | Torti Frank Director | Immunovant, Inc. (IMVT) | 02-Apr-24 | Grant | 120,400 | -- | -- | 23% 515.27K to 635.67K | |
| 23-Feb-24 4:14 PM View: | Butchko Julia G. Chief Development Officer | Immunovant, Inc. (IMVT) | 22-Feb-24 | Private Sale | 2,146 | $36.15 | $77,577.90 | (< 1%) 409.96K to 407.82K | |
| 23-Feb-24 4:11 PM View: | Salzmann Peter Chief Executive Officer Director | Immunovant, Inc. (IMVT) | 22-Feb-24 | Private Sale | 13,454 | $36.15 | $486,362.00 | (1%) 944.68K to 931.23K | |
| 23-Feb-24 4:16 PM View: | MacIas William L. Chief Medical Officer | Immunovant, Inc. (IMVT) | 22-Feb-24 | Private Sale | 2,221 | $36.15 | $80,289.20 | (< 1%) 333.17K to 330.95K | |
| 23-Feb-24 4:18 PM View: | Levine Mark S. Chief Legal Officer | Immunovant, Inc. (IMVT) | 22-Feb-24 | Private Sale | 2,134 | $36.15 | $77,144.10 | (< 1%) 304.1K to 301.97K | |
| 23-Feb-24 4:21 PM View: | Barnett Eva Renee Chief Financial Officer | Immunovant, Inc. (IMVT) | 22-Feb-24 | Private Sale | 2,930 | $36.15 | $105,920.00 | (< 1%) 323.35K to 320.42K | |
| 29-Jan-24 4:11 PM View: | Geffner Michael Chief Medical Officer | Immunovant, Inc. (IMVT) | 26-Jan-24 | Private Sale | 10,101 | $37.92 | $383,012.00 | (10%) 100.0K to 89.9K | |
| 29-Jan-24 4:12 PM View: | Levine Mark S. Chief Legal Officer | Immunovant, Inc. (IMVT) | 26-Jan-24 | Private Sale | 3,027 | $37.92 | $114,778.00 | (< 1%) 307.13K to 304.1K | |
| 19-Jan-24 4:04 PM View: | MacIas William L. Chief Medical Officer | Immunovant, Inc. (IMVT) | 18-Jan-24 | Private Sale | 424 | $41.03 | $17,396.70 | (< 1%) 333.6K to 333.17K | |
| 12-Jan-24 4:34 PM View: | Barnett Eva Renee Chief Financial Officer | Immunovant, Inc. (IMVT) | 11-Jan-24 | Private Sale | 3,515 | $41.83 | $147,023.00 | (1%) 326.87K to 323.35K | |
| 09-Jan-24 4:18 PM View: | Salzmann Peter Chief Executive Officer Director | Immunovant, Inc. (IMVT) | 05-Jan-24 | Private Sale | 3,824 | $38.59 | $147,568.00 | (< 1%) 948.51K to 944.68K | |
| 09-Jan-24 4:20 PM View: | Butchko Julia G. Chief Development Officer | Immunovant, Inc. (IMVT) | 05-Jan-24 | Private Sale | 1,297 | $38.59 | $50,051.20 | (< 1%) 411.26K to 409.96K | |
| 05-Dec-23 4:28 PM View: | Pande Atul Director | Immunovant, Inc. (IMVT) | 01-Dec-23 | Private Sale | 12,350 | $39.73 | $490,667.00 | (11%) 115.51K to 103.16K | |
| 05-Dec-23 4:25 PM View: | Migausky George V Director | Immunovant, Inc. (IMVT) | 01-Dec-23 | Private Sale | 12,700 | $39.73 | $504,567.00 | (10%) 122.51K to 109.81K | |
| 05-Dec-23 4:30 PM View: | Fromkin Drew J Director | Immunovant, Inc. (IMVT) | 01-Dec-23 | Private Sale | 12,350 | $39.73 | $490,697.00 | (12%) 101.01K to 88.66K | |
| 24-Nov-23 2:41 PM View: | Levine Mark S. Chief Legal Officer | Immunovant, Inc. (IMVT) | 22-Nov-23 | Private Sale | 3,252 | $32.78 | $106,598.00 | (1%) 310.38K to 307.13K | |
| 24-Nov-23 2:51 PM View: | Barnett Eva Renee Chief Financial Officer | Immunovant, Inc. (IMVT) | 22-Nov-23 | Private Sale | 4,055 | $32.78 | $132,920.00 | (1%) 330.92K to 326.87K | |
| 24-Nov-23 2:47 PM View: | Butchko Julia G. Chief Development Officer | Immunovant, Inc. (IMVT) | 22-Nov-23 | Private Sale | 3,265 | $32.78 | $107,024.00 | (< 1%) 414.52K to 411.26K | |
| 24-Nov-23 2:55 PM View: | Salzmann Peter Chief Executive Officer Director | Immunovant, Inc. (IMVT) | 22-Nov-23 | Private Sale | 16,217 | $32.78 | $531,581.00 | (2%) 964.73K to 948.51K | |
| 24-Nov-23 2:45 PM View: | MacIas William L. Chief Medical Officer | Immunovant, Inc. (IMVT) | 22-Nov-23 | Private Sale | 3,265 | $32.78 | $107,024.00 | (< 1%) 336.86K to 333.6K | |
| 27-Oct-23 4:04 PM View: | Levine Mark S. Chief Legal Officer | Immunovant, Inc. (IMVT) | 25-Oct-23 | Private Sale | 4,107 | $34.66 | $142,349.00 | (1%) 314.49K to 310.38K | |
| 20-Oct-23 4:06 PM View: | MacIas William L. Chief Medical Officer | Immunovant, Inc. (IMVT) | 19-Oct-23 | Private Sale | 530 | $36.80 | $19,504.00 | (< 1%) 337.39K to 336.86K | |
| 11-Oct-23 4:11 PM View: | Barnett Eva Renee Chief Financial Officer | Immunovant, Inc. (IMVT) | 10-Oct-23 | Private Sale | 4,557 | $36.92 | $168,244.00 | (1%) 335.48K to 330.92K | |
| 06-Oct-23 5:15 PM View: | Butchko Julia G. Chief Development Officer | Immunovant, Inc. (IMVT) | 05-Oct-23 | Private Sale | 1,735 | $36.24 | $62,885.00 | (< 1%) 416.26K to 414.52K | |
| 06-Oct-23 5:10 PM View: | Salzmann Peter Chief Executive Officer Director | Immunovant, Inc. (IMVT) | 05-Oct-23 | Private Sale | 5,239 | $36.24 | $189,887.00 | (< 1%) 969.97K to 964.73K | |
| 04-Oct-23 5:15 PM View: | Roivant Sciences Ltd. Director 10% Owner | Immunovant, Inc. (IMVT) | 02-Oct-23 | Grant | 4,473,680 | $38.00 | $170,000,000.00 | 6% 73.81M to 78.28M | |
| 04-Oct-23 5:15 PM View: | Roivant Sciences Ltd. Director 10% Owner | Immunovant, Inc. (IMVT) | 02-Oct-23 | Purchase | 1,526,320 | $38.00 | $58,000,000.00 | 2% 78.28M to 79.81M | |
| 01-Sep-23 4:08 PM View: | Salzmann Peter Chief Executive Officer Director | Immunovant, Inc. (IMVT) | 30-Aug-23 | Private Sale | 56,774 | $22.02 | $1,250,340.00 | (6%) 1.03M to 969.97K |
